Figure 4From: Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR Progression-free survival curves in subgroup patients with epidermal growth factor receptor mutation positive (A) and negative (B) according to phosphorylated tyrosine (pTyr)1068 espression. Back to article page